B-Cell therapies in the treatment of multiple sclerosis
Professors Celia Oreja-Guevara and Patrick Vermersch explore how B-cell therapies are reshaping MS treatment strategies, from first-line decisions to long-term outcomes.
This educational webinar explores the evolving role of B-cell therapies in the treatment of multiple sclerosis (MS). Professors Celia Oreja-Guevara and Patrick Vermersch provide a comprehensive overview of B-cell immunology, mechanisms of action of anti-CD20 monoclonal antibodies, and the latest clinical evidence supporting their use across relapsing and progressive forms of MS. The session also discusses comparative data on efficacy, safety, administration routes, and long-term patient outcomes, offering clinicians practical guidance for therapeutic decision-making.
Watch the full webinar recording to explore how B-cell therapies are shaping the future of MS treatment—now available on demand.
Find out about the speakers:


